Published 2006 | Version v1
Miscellaneous Open

Radiation protection in brachytherapic treatment of prostatic carcinoma

  • 1. Catania Univ. Hospital, 'Vittorio Emanuele, Ferrarotto e Santo Bambino' (Italy)
  • 2. Messina Univ., Dept. of Protezionistica Ambientale, Sanitaria, Sociale ed Industriale (Italy)

Description

Purpose: To evaluate absorbed doses for medical staff and general public deriving from prostate brachytherapy with I-125 seeds. Methods And Materials: Radiation exposure measurements were made for staff and on a subset of 64 patients of the 100 trans perineal I-125 implanted seeds implants at the Vittorio Emanuele, Ferrarotto e Santo Bambino Universitary Hospital. Results: Absorbed doses for operators are very low when using radiation safety devices. The exposure rate at the anterior skin surface due to I-125 implanted seeds ranged from 32 to 120 μSv/hour. Conclusions: The evaluation of dose measurements shows that radiation risk associated to this practice is very low, both for staff that for critical group of population, if they follow the specific radioprotection statements supplied by health physicists. (authors)

Availability note (English)

Available from INIS in electronic form

Files

38056692.pdf

Files (94.4 kB)

Name Size Download all
md5:3da43384686e004cd86f297f05d1feea
94.4 kB Preview Download

Additional details

Publishing Information

Imprint Pagination
7 p.
Report number
INIS-FR--6070

Conference

Title
from knowledge to action
Acronym
Second European IRPA congress on radiation protection - Radiation protection
Dates
15-19 May 2006
Place
Paris (France)